Literature DB >> 23332368

N-(Phenoxyalkyl)amides as MT(1) and MT(2) ligands: antioxidant properties and inhibition of Ca(2+)/CaM-dependent kinase II.

Alessia Carocci1, Alessia Catalano, Claudio Bruno, Angelo Lovece, Maria Grazia Roselli, Maria Maddalena Cavalluzzi, Francesco De Santis, Annalisa De Palma, Maria Rosaria Rusciano, Maddalena Illario, Carlo Franchini, Giovanni Lentini.   

Abstract

Recently a series of chiral N-(phenoxyalkyl)amides have been reported as potent MT(1) and MT(2) melatonergic ligands. Some of these compounds were selected and tested for their antioxidant properties by measuring their reducing effect against oxidation of 2',7'-dichlorodihydrofluorescein (DCFH) in the DCFH-diacetate (DCFH-DA) assay. Among the tested compounds, N-[2-(3-methoxyphenoxy)propyl]butanamide displayed potent antioxidant activity that was stereoselective, the (R)-enantiomer performing as the eutomer. This compound displayed strong cytoprotective activity against H(2)O(2)-induced cytotoxicity resulting slightly more active than melatonin, and performed as Ca(2+)/calmodulin-dependent kinase II (CaMKII) inhibitor, too.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23332368     DOI: 10.1016/j.bmc.2012.12.017

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  7 in total

1.  Identification of new biologically active synthetic molecules: comparative experimental and theoretical studies on the structure-antioxidant activity relationship of cyclic 1,3-ketoamides.

Authors:  Riad Mustapha Kerbadou; Ratiba Hadjadj Aoul; Aouicha Benmaati; Assya Taleb; Salih Hacini; Hadjira Habib Zahmani
Journal:  J Mol Model       Date:  2021-03-19       Impact factor: 1.810

Review 2.  Melatonin and ubiquitin: what's the connection?

Authors:  Jerry Vriend; Russel J Reiter
Journal:  Cell Mol Life Sci       Date:  2014-06-12       Impact factor: 9.261

3.  Acetylated hyaluronic acid: enhanced bioavailability and biological studies.

Authors:  Carmela Saturnino; Maria Stefania Sinicropi; Ortensia Ilaria Parisi; Domenico Iacopetta; Ada Popolo; Stefania Marzocco; Giuseppina Autore; Anna Caruso; Anna Rita Cappello; Pasquale Longo; Francesco Puoci
Journal:  Biomed Res Int       Date:  2014-07-08       Impact factor: 3.411

Review 4.  Melatonergic drugs in development.

Authors:  Alessia Carocci; Alessia Catalano; Maria Stefania Sinicropi
Journal:  Clin Pharmacol       Date:  2014-09-18

5.  Natural Scaffolds with Multi-Target Activity for the Potential Treatment of Alzheimer's Disease.

Authors:  Luca Piemontese; Gabriele Vitucci; Marco Catto; Antonio Laghezza; Filippo Maria Perna; Mariagrazia Rullo; Fulvio Loiodice; Vito Capriati; Michele Solfrizzo
Journal:  Molecules       Date:  2018-08-29       Impact factor: 4.411

6.  Synthesis and characterization of new bivalent agents as melatonin- and histamine H3-ligands.

Authors:  Daniele Pala; Laura Scalvini; Alessio Lodola; Marco Mor; Lisa Flammini; Elisabetta Barocelli; Valeria Lucini; Francesco Scaglione; Silvia Bartolucci; Annalida Bedini; Silvia Rivara; Gilberto Spadoni
Journal:  Int J Mol Sci       Date:  2014-09-12       Impact factor: 5.923

7.  N-thioalkylcarbazoles derivatives as new anti-proliferative agents: synthesis, characterisation and molecular mechanism evaluation.

Authors:  Maria Stefania Sinicropi; Domenico Iacopetta; Camillo Rosano; Rosario Randino; Anna Caruso; Carmela Saturnino; Noemi Muià; Jessica Ceramella; Francesco Puoci; Manuela Rodriquez; Pasquale Longo; Maria Rosaria Plutino
Journal:  J Enzyme Inhib Med Chem       Date:  2018-12       Impact factor: 5.051

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.